Methocarbamol liquid 100mg/ml, RX, glass vial
Reported: January 9, 2019 Initiated: January 2, 2019 #D-0400-2019
Product Description
Methocarbamol liquid 100mg/ml, RX, glass vial
Reason for Recall
Lack of sterility assurance.
Details
- Recalling Firm
- Hiers Enterprises, LLC dba Northwest Compounding Pharmacy
- Units Affected
- 300 ml
- Distribution
- Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients. These are compounded products - labels vary for each compound - specific to each patient. Firm did not provide labeling.
- Location
- Roseburg, OR
Frequently Asked Questions
What product was recalled? ▼
Methocarbamol liquid 100mg/ml, RX, glass vial. Recalled by Hiers Enterprises, LLC dba Northwest Compounding Pharmacy. Units affected: 300 ml.
Why was this product recalled? ▼
Lack of sterility assurance.
Which agency issued this recall? ▼
This recall was issued by the FDA Drug on January 9, 2019. Severity: Moderate. Recall number: D-0400-2019.
Related Recalls
NHTSA Critical
LEXUS 2025: POWER TRAIN:AUTOMATIC TRANSMISSION
LEXUS · 2026-02-18
NHTSA Critical
CADILLAC,CHEVROLET,GMC 2022: POWER TRAIN:AUTOMATIC TRANSMISSION:CONTROL MODULE:SOFTWARE
CADILLAC,CHEVROLET,GMC · 2026-02-13
NHTSA Critical
CHEVROLET,GMC 2020-2022: POWER TRAIN:AUTOMATIC TRANSMISSION:CONTROL MODULE:SOFTWARE
CHEVROLET,GMC · 2026-02-12
NHTSA Critical
CADILLAC 2024: BACK OVER PREVENTION:SOFTWARE
CADILLAC · 2026-02-12
NHTSA Critical
NISSAN 2024-2025: FUEL SYSTEM, GASOLINE:FUEL INJECTION SYSTEM:THROTTLEBODY/MANIFOLD
NISSAN · 2026-02-12